Clinical Trial Update: Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the short and intermediate-term effects of dapagliflozin on left ventricular remodeling in patients with anterior STEMI is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mohamed Nabil Elkholy | Conditions: STEMI | Phase 3 | Status: RECRUITING